Zeo ScientifiXZEOX 50 PB Ratio is 19.56 as of Jul. 01, 2026, which is 10% below its 10-year median of 21.76. GuruFocus rates ZEOX with a GF Score™ of 50/100 and a GF Value™ of $2.67 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,229 Biotechnology companies, Zeo ScientifiX ranks worse than 93.08% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-01), Zeo ScientifiX's share price is $1.78. Zeo ScientifiX's Book Value per Share for the quarter that ended in Apr. 2026 was $0.09. Hence, Zeo ScientifiX's PB Ratio of today is 19.56.
Good Sign:
Zeo ScientifiX Inc stock PB Ratio (=19.23) is close to 3-year low of 18.68.
The historical rank and industry rank for Zeo ScientifiX's PB Ratio or its related term are showing as below:
ZEOX'
s PB Ratio Range Over the Past 10 Years
Min: 10.75 Med: 21.76 Max: 36.26
Current: 19.78
During the past 13 years, Zeo ScientifiX's highest PB Ratio was 36.26. The lowest was 10.75. And the median was 21.76.
ZEOX's PB Ratio is ranked worse than 93.08% of 1229
companies
in the Biotechnology industry
Industry Median: 2.87
vs ZEOX: 19.78
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Zeo ScientifiX was 196.20% per year. The lowest was -352.30% per year. And the median was 17.90% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Zeo ScientifiX PB Ratio Related Terms
Zeo ScientifiX PB Ratio Historical Data
* Premium members only.
The historical data trend for Zeo ScientifiX's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Zeo ScientifiX's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zeo ScientifiX PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Zeo ScientifiX's PB Ratio distribution charts can be found below:
* The bar in red indicates where Zeo ScientifiX's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Zeo ScientifiX's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Zeo ScientifiX (ZEOX) has a PB Ratio of 19.56 as of Jul. 01, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Zeo ScientifiX and its competitors. This is 10% below median its historical median of 21.76. Over the past decade, Zeo ScientifiX's PB Ratio has ranged from 10.75 to 36.26. According to the industry distribution chart, Zeo ScientifiX ranks #1144 out of 1229 companies in the Biotechnology industry, placing it in the top 93.1%.
Is Zeo ScientifiX's PB Ratio too high?
Zeo ScientifiX's current PB Ratio of 19.56 is 10% below median its 10-year median of 21.76. Over the past 10 years, this metric has ranged from a low of 10.75 to a high of 36.26. The Biotechnology industry median PB Ratio is 2.87. Zeo ScientifiX's value of 19.56 is 581.5% above this industry median. Based on the distribution chart, Zeo ScientifiX ranks #1144 out of 1229 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Zeo ScientifiX has a GF Score™ of 50/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Zeo ScientifiX's PB Ratio compare to JUNS and HOOK?
According to the Biotechnology industry distribution chart, Zeo ScientifiX ranks #1144 out of 1229 companies for PB Ratio. This places Zeo ScientifiX in the lower half of its industry. The industry median PB Ratio is 2.87. Zeo ScientifiX's value of 19.56 is 581.5% above this benchmark. Historically, Zeo ScientifiX's own PB Ratio has ranged from 10.75 to 36.26 over the past decade. While the company's 10-year median is 21.76 vs. the industry median of 2.87, Zeo ScientifiX has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Biotechnology company?
The median PB Ratio among Biotechnology companies is 2.87, based on 1,229 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zeo ScientifiX's current PB Ratio of 19.56 is 581.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Zeo ScientifiX and its competitors. For the Biotechnology industry, the median PB Ratio is 2.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zeo ScientifiX's current PB Ratio is 19.56, which is 10% below median its own 10-year median of 21.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zeo ScientifiX stock overvalued right now?
Based on GuruFocus' analysis, Zeo ScientifiX (ZEOX) is currently considered Possible Value Trap. The stock's GF Value™ is $2.67, compared to a current price of $1.78 — trading 33.3% below its estimated fair value. The current PB Ratio is 19.56, which is 10% below median its 10-year median of 21.76 and 581.5% above the Biotechnology industry median of 2.87. Zeo ScientifiX's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Zeo ScientifiX (ZEOX), the current PB Ratio is 19.56 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zeo ScientifiX (ZEOX) Overvalued in 2026?
Based on GuruFocus' analysis, Zeo ScientifiX stock appears to be undervalued.
The current stock price of $1.78 is trading 33.3% below its estimated GF Value™ of $2.67.
GuruFocus considers Zeo ScientifiX to be Possible Value Trap.
Key valuation signals for ZEOX:
PB Ratio: 19.56 (10% below median its 10-year median of 21.76)
GF Value™: $2.67 vs. price of $1.78 (33.3% below fair value)
Industry Position: 581.5% above the Biotechnology median (#1144 of 1229)
No single metric tells the full story. See the ZEOX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zeo ScientifiX Inc is a clinical-stage biopharmaceutical company located inside Nova Southeastern University's Collaborative Center for Research in Davie, Florida. The Company is a clinical-stage biopharmaceutical company principally focusing on the development of biological therapeutics for the treatment of degenerative diseases and regenerative medicine. The Company's proprietary products, including Zofin, are derived from perinatal sources and manufactured to retain the naturally occurring extracellular vesicles, proteins and cell secreted nanoparticles and Patient Pure X (PPX ), an autologous biologic containing a nanoparticle fraction that is precipitated from a patient's own peripheral blood (RAAM Products).
50GF Score
Get the complete analysis for ZEOX
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ZEOX has been successfully added to your 
